Search Results 21-30 of 16929 for Semaglutide

  1. Mayo Clinic Minute: What's the skinny on weight-loss drugs? VIDEO AUDIO It's a medication called semaglutide — better known by

    VIDEO. AUDIO. It's a medication called semaglutide — better known by the brand names Ozempic and Wegovy. Ozempic is approved by the Food and Drug.

  2. Effects of NNC0194-0499, Cagrilintide, And Semaglutide Alone Or Combined With Semaglutide On Liver Damage And Alcohol Use In Alcohol-Related Liver Disease - Mayo Clinic

    Effects of NNC0194-0499, Cagrilintide, And Semaglutide Alone Or Combined With Semaglutide On Liver Damage And Alcohol Use In Alcohol-Related Liver Disease.

  3. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Insulin Degludec; Insulin Detemir; Insulin Glulisine; Insulin Lispro, Recombinant; Liraglutide; Nateglinide; Repaglinide; Semaglutide; Tolazamide; Tolbutamide ...

  4. Publications - Chris L. Sola, D.O. - Mayo Clinic

    Al-Soleiti M, Leung JG, Mubaydeen T, Markota M, Abulseoud O, Singh B, Sola CL. Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in ...

  5. Effect of Tirzepatide on Physical Function in Postmenopausal Women With Obesity - Mayo Clinic

    Semaglutide and tirzepatide are potent antiobesity medications. Therefore, our overarching goal is to determine the effect of weight loss induced by the new ...

  6. Liver Biopsy Clinical Trials - Mayo Clinic Research

    The primary objective of this study is to evaluate whether the combination of semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firsocostat ...

  7. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Semaglutide (Ozempic, Rybelsus, Wegovy); Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release ...

  8. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    About this study. The purpose of this study is to compare effects of weekly SQ semaglutide 2.4mg SQ, SQ tirzepatide 10mg, and placebo administered for 24 ...

  9. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

    ... semaglutide. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  10. Genetic test predicts response to weight-loss drugs - Mayo Clinic News Network

    The team has conducted additional studies to predict response to semaglutide, another GLP-1 medication (sold under the brand names Ozempic and Wegovy), and ...